This letter from Prescrire to the Editor of Health Affairs, in response to "Decline in Placebo-controlled trial results suggests new directions for comparative effectiveness research" (Health Affairs, June 2013), was published in their October 2013 issue. In its letter, Prescrire argues that a drug approval system based on placebo-controlled trials does not encourage real therapeutic progress. Quite the contrary, it opens the door to therapeutic regression.